We thank Dr. U. Ashery for the gift of NPY-mRFP cDNA. We thank Drs. M. J. Kofron, L. Mittleman, M. Shaharbani, and Y. Zilberstein for invaluable assistance with microscopy and image analyses. We also thank Dr. Joseph Orly for critical reading of this manuscript. &#160;This work was supported by a grant from the Israel Science Foundation, founded by&#160;the Israel Academy for Sciences (1139/12 to R.S-E.).

1. Preparation of RBL Cell Culture Media
<ol>
	<li>Mix 500 ml of low glucose Dulbecco&#39;s modified Eagle&#39;s medium (DMEM) with 56&#160;ml of fetal bovine serum (this makes 10% FBS), and then add 5.5 ml of penicillin streptomycin (this makes ~1% PEST).</li>
	<li>Filter the media by using 500-1,000 ml Bottle-Top Vacuum Filters with 0.22 &#956;m pore size and store at 4 &#176;C.</li>
</ol>
2. Culture of RBL Cells
<ol>
	<li>Grow RBL cells in a humidified atmosphere of 5% CO2 at 37 &#176;C in either plates or flasks. RBL cells that are growing in 10 cm plates should be supplemented with 10 ml medium and form confluent monolayer of ~107 cells/plate.</li>
	<li>When the cell layer is approaching confluence, replate&#160;the culture at a lower density.
	<ol>
		<li>Remove the culture medium from the plate/flask using a sterile pasteur pipette connected to vacuum.</li>
		<li>Rinse the cell monolayer with prewarmed (37 &#176;C) 0.25% trypsin/EDTA that covers the whole monolayer (the volume depends on the size of culture plate/flask; 2 ml for 10 cm plate). This will detach the cells.</li>
		<li>Alternatively, rinse the cell monolayer with Phosphate buffered saline (PBS), remove the PBS and add prewarmed (37 &#176;C) trypsin/EDTA. This step detaches the cells faster.</li>
		<li>Place the plate/flask in an incubator at 37 &#176;C (no more than 10 min).</li>
		<li>Inspect the cells under the optical microscope to check if they have detached. If the cells did not detach after 10 min, gently tap on the plate/flask.</li>
		<li>Add medium to the culture plate/flask to suspend the cells (the volume of the medium should be at least 2-fold larger than the volume of the trypsin solution).</li>
		<li>Pellet the cells by centrifugation for 3 min at 200 g at 25 &#176;C.</li>
		<li>Resuspend the cells in medium. Dilute the cells by 1:10 and seed in a new culture dish. Incubate the cells for 48-72 hr, until they reach approximately 90% confluence.</li>
		<li>Repeat the same procedure (section 2.2.1-2.2.8) for up to 3 months (30 passages).</li>
	</ol>
	</li>
</ol>
3. Preparation of Transfection Media.
<ol>
	<li>Prepare a 100 mM solution of K-Pipes pH 7, 1 mM solution of Ca2+ acetate and 100 mM solution of Mg2+ acetate.</li>
	<li>Dilute the 100 mM solution of K-Pipes pH 7 into 20 mM using DMEM media, add the 1 mM solution of Ca2+ acetate to a final concentration of 10 &#956;M and 100 mM solution of Mg2+ acetate to a final concentration of 2 mM.</li>
	<li>Weigh&#160;Potassium glutamate and add to the solution to a final concentration of 128 mM, mix well and keep at 4 &#176;C until use. Keep the remaining solutions (i.e., K-Pipes, Ca2+ acetate, Mg2+ acetate) at -20 &#176;C.</li>
</ol>
4. Transfection of RBL Cells
<ol>
	<li>Remove the culture medium from the plate/flask using a sterile pasteur pipette connected to vacuum.</li>
	<li>Rinse the cell monolayer with prewarmed (37 &#176;C) trypsin/EDTA that should cover the whole monolayer. Place the plate/flask in an incubator at 37 &#176;C (no more than 10 min). Check if the cells have detached using the optical microscope.</li>
	<li>Add medium to the culture plate/flask to suspend the cells (the volume of the media should be at least 2-larger more than the volume of the trypsin solution).</li>
	<li>Count the cell number using hemocytometer.</li>
	<li>Pellet 1.5 &#215; 107 cells by centrifugation for 3 min at 200 x g at 25 &#176;C. Discard the supernatants and add 280 &#181;l of transfection medium. Transfer the reaction mix into 4 mm cuvette.</li>
	<li>Add 20 &#956;g of NPY-mRFP plasmid and either 30 &#956;g of control empty plasmid or a tested plasmid. The final volume of the reaction mix should be 300 &#956;l.</li>
	<li>Immediately place on ice for 10 min. Wipe the cuvette from residual water and proceed to electroporation at 300 V for 9 msec.</li>
	<li>For measurements of exocytosis, replate the cells immediately in 24 well tissue culture dishes containing 300 &#956;l medium. Add 8 &#956;l of the reaction mix (4 &#215; 105 cells) to each well. Add 4 &#215; 105 non transfected cells to additional wells for control. Prepare enough wells for to have at least duplicate wells for each treatment for every transfection.</li>
	<li>For time lapse microscopy, replate the cells immediately in an 8-well chamber borosilicate coverglass system containing 80 &#956;l medium. Add 1.5 &#956;l of the reaction mix (7.5 &#215; 104 cells) to each chamber. (Try to avoid using the chambers at the edge of the coverglass, the chambers at the center of the coverglass are easier to image). 
	NOTE: Importantly, not all the cells response to a trigger and occasionally the time-lapse microscopy is abrogated due to loss of focus and drift&#160;of the 8-well chamber borosilicate coverglass system. Therefore, prepare at least 8 chambers for each treatment for each transfection.</li>
	<li>For sensitizing the cells for Fc&#949;RI mediated activation, add 1 &#181;g/ml of mouse DNP specific monoclonal IgE to the media (incubate the cells with IgE for at least 2 hr).</li>
	<li>After 18-24 hr use a fluorescent microscope to confirm that the cells express the plasmids. The excitation and emission wavelengths of mRFP fluorescence are: &#955;Ex 584, &#955;Em 607 nm. NPY-mRFP should appear in vesicular structures which correspond to the SGs.&#160;If the second gene of interest is fused to a fluorescent tag use a fluorescent microscope to confirm the co-expression of both plasmids at the same cells. For example, if the tested gene is fused to GFP, The excitation and emission wavelengths of GFP fluorescence are: &#955;Ex 488, &#955;Em 507 nm. The GFP tagged protein should appear at the same cells that express NPY-mRFP.</li>
	<li>For exocytosis measurements proceed to step 5 and for time lapse microscopy, proceed to step 6.</li>
</ol>
5. Measuring NPY-mRFP Exocytosis
<ol>
	<li>Preparation of Tyrode buffer:
	<ol>
		<li>Prepare a solution of 54 mM KCl, 20 mM MgCl2, 2.74 M NaCl and 8 mM NaH2PO4 in DDW. Mix well and store at 4 &#176;C. This step is for preparation of 20x Tyrode buffer.</li>
		<li>Prepare a solution of 20 mM Hepes pH 7, 1.8 mM CaCl2, 1 mg/ml BSA, 5.6 mM glucose and 1 to 20 dilution of Tyrode 20x in DDW and mix well. This step is for preparation of 1x Tyrode buffer.</li>
		<li>Aliquot the 1x Tyrode buffer and store at -20 &#176;C. Avoid repeated freezing and thawing.</li>
	</ol>
	</li>
	<li>Remove the culture medium from the 24 well plate and wash 3 times with Tyrode buffer. Prepare unstimulated cells by adding 200 &#956;l Tyrode buffer to control wells.</li>
	<li>Prepare 10 &#956;l/well of 20X concentrated activating reagent [(e.g. 1,000 ng/ml DNP-BSA or DNP-HSA (Ag), 200 &#181;M Ca2+ionophore (e.g. A23187), and a combination of 20 &#181;M Ca2+&#160;ionophore and 1,000 nM 12-O-&#160; tetradecanoylphorbol-13-acetate (TPA)]. If the reagents are stored in DMSO, dilute the reagents into 20x concentration in Tyrode buffer containing 1% DMSO.&#160;Incubate at 37 &#176;C for 30 min.</li>
	<li>Remove the supernatants of each well carefully to a 96 well plate, place on ice and avoid from light. (The supernatants contain the chimeric peptide NPY-mRFP that was released from the cells).</li>
	<li>Add 200 &#956;l Tyrode buffer containing 0.5% Triton X-100 to each well and incubate at 37 &#176;C for 10 min. (This step is important for preparation of cell lysates that contain the remaining of NPY-mRFP that was not released from the cells). Collect the cell lysates and transfer to a 96 well plate, place on ice and avoid from light.</li>
	<li>Measure the fluorescence of the cell supernatants and cell lysates using a fluorescence plate reader, using a 590-, 20 nm bandwidth excitation filter and 635-, 35 nm bandwidth emission filter.</li>
	<li>Calculate the percentage of NPY-mRFP released: 
	NOTE: The fluorescence reader measure arbitrary fluorescence units (AFU). AFU values depend on the machine and its sensitivity and the transfection efficiency.
	<ol>
		<li>Set the autofluorescence of nontransfected RBL cells as blank. Divide the AFU of each supernatant to the total fluorescence (AFU of the supernatants + AFU of the corresponding lysate) and multiply by 100.</li>
	</ol>
	</li>
</ol>
6. Time-lapse Microscopy of Exocytosis
<ol>
	<li>Seed 7.5 &#215; 104 of the transfected cells/chamber in an 8-well chamber borosilicate coverglass system. After 18-24 hr, remove the culture medium from the chambers and wash 3 times with Tyrode buffer</li>
	<li>Add 72 &#956;l of Tyrode buffer to each chamber. Dilute the activating reagents in Tyrode buffer to 10x concentration.</li>
	<li>Use a confocal fluorescence microscope equipped with a heated chamber (37 &#176;C) and CO2 controller (4.8%) and a 40X or 63X objective. Turn on the microscope systems: mercury lamp, computer, and lasers. Make sure that the heated chamber is at the right temperature before starting the experiment.</li>
	<li>Place the chamber in the heated chamber and make sure that the chamber is installed correctly and stable.</li>
	<li>Turn on the fluorescence light according to the relevant fluorophore and visualize transfected cells. Turn off fluorescence once a cell of interest is in the field in order to minimize bleaching and cytotoxicity. It is important that this field will contain about 2-3 transfected cells. The transfected cells should be well spread but not touching each other.</li>
	<li>Adjust the laser power (depending on the microscope) to minimize noise and oversaturation as well as toxicity, and set the gain and offset to modify the signal to noise ratio. Scan fast in order to minimize the duration of laser exposition (average 2).</li>
	<li>Adjust the pinhole size to a maximum, this enables decreasing the laser power and to maintain images focused for a long period of time. If desired, set the parameters for the Z stack to reconstruct the image in three dimensional, adjust the pinhole size to 1 airy unit (AU) that gives the best signal to noise ratio and acquire successive scanning of two-dimensional confocal optical slices in the z-axes with optical slices &#8804;0.7 &#956;m.</li>
	<li>Set the interval time between each acquisition to 15-30 sec and the duration of total acquisition to 15&#160;min and start acquiring images. After 5&#160;min of acquisition pause the time series. Add 8 &#956;l of the 10x trigger and continue the acquisition immediately.</li>
	<li>Save the pictures, perform deconvolution using a deconvolution software and reconstruct the stacks to three dimensional images and to a movie using Imaris software.</li>
</ol>
7. Image Analyses
<ol>
	<li>Import the data from the deconvoluted time series images that were obtained by the confocal fluorescence microscope to Imaris software. This software reads more than 40 microscopy files. If the software cannot read the files; convert the files to tif files and import.</li>
	<li>To add time points to the end of an open data set press edit -&#62; Add Time Points and import the new data set.</li>
	<li>Create surface of the mRFP channel using surface wizard option. Choose the default algorithm. Choose the channel of NPY-mRFP. Mark the smoothing option to reduce noise. To avoid loss of small details reduce the area detail level to 0.05 &#956;m.</li>
	<li>Set the intensity threshold. New gray surface will be displayed. Go to &#8220;Settings&#8221; and switch the style from &#8220;Center point&#8221; to &#8220;Surface&#8221;.</li>
	<li>Go to the statistic tab in the properties of selected object, select the detailed tab and the specific value such as fluorescence intensity, volume etc.</li>
	<li>Review the data and confirm that the values are compatible with the images. For example, two or more adjacent granules might be measured as one bigger granule. For quantifying the average granule size divide the size of the merged granules to the actual number of granules.</li>
	<li>Export the desired data sets to Excel files and analyze the data.</li>
</ol>f

<ol>
	<li>Abonia, J. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Involvement+of+mast+cells+in+eosinophilic+esophagitis.">Involvement of mast cells in eosinophilic esophagitis.</a> J Allergy Clin Immunol. 126 (1), 140-149 (2010).</li><li>Galli, S. J., Tsai, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mast+cells+in+allergy+and+infection:+versatile+effector+and+regulatory+cells+in+innate+and+adaptive+immunity.">Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity.</a> Eur J Immunol. 40 (7), 1843-1851 (2010).</li><li>Ribatti, D., Crivellato, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+controversial+role+of+mast+cells+in+tumor+growth.">The controversial role of mast cells in tumor growth.</a> International Review of Cell and Molecular Biology. 275, 89-131 (2009).</li><li>Ribatti, D., Crivellato, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mast+cells,+angiogenesis+and+cancer.">Mast cells, angiogenesis and cancer.</a> Adv Exp Med Biol. 716, 270-288 (2011).</li><li>Tsai, M., Grimbaldeston, M., Galli, S. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mast+cells+and+immunoregulation/immunomodulation.">Mast cells and immunoregulation/immunomodulation.</a> Adv Exp Med Biol. 716, 186-211 (2011).</li><li>Vries, V. C., Noelle, R. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mast+cell+mediators+in+tolerance.">Mast cell mediators in tolerance.</a> Curr Opin Immunol. 22 (5), 643-648 (2010).</li><li>Kirshenbaum, A. S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Demonstration+that+human+mast+cells+arise+from+a+progenitor+cell+population+that+is+CD34(+),+c-kit(+),+and+expresses+aminopeptidase+N+(CD13).">Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13).</a> Blood. 94 (7), 2333-2342 (1999).</li><li>Metcalfe, D. D., Baram, D., Mekori, Y. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mast+cells.">Mast cells.</a> Physiol Rev. 77 (4), 1033-1079 (1997).</li><li>Gilfillan, A. M., Austin, S. J., Metcalfe, D. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mast+cell+biology:+introduction+and+overview.">Mast cell biology: introduction and overview.</a> Adv Exp Med Biol. 716, 2-12 (2011).</li><li>Rivera, J., Gilfillan, A. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Molecular+regulation+of+mast+cell+activation.">Molecular regulation of mast cell activation.</a> J Allergy Clin Immunol. 117 (6), 1214-1225 (2006).</li><li>Rivera, J., Gilfillan, A. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Molecular+regulation+of+mast+cell+activation.">Molecular regulation of mast cell activation.</a> Journal of Allergy and Clinical Immunology. 117 (6), 1214 (2006).</li><li>Lagunoff, D., Martin, T. W., Read, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Agents+that+release+histamine+from+mast+cells.">Agents that release histamine from mast cells.</a> Annu Rev Pharmacol Toxicol. 23, 331-351 (1983).</li><li>Depinay, N., Hacini, F., Beghdadi, W., Peronet, R., Mecheri, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mast+cell-dependent+down-regulation+of+antigen-specific+immune+responses+by+mosquito+bites.">Mast cell-dependent down-regulation of antigen-specific immune responses by mosquito bites.</a> J Immunol. 176 (7), 4141-4146 (2006).</li><li>Abel, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Staphylococcus+aureus+evades+the+extracellular+antimicrobial+activity+of+mast+cells+by+promoting+its+own+uptake.">Staphylococcus aureus evades the extracellular antimicrobial activity of mast cells by promoting its own uptake.</a> J Innate Immun. 3 (5), 495-507 (2011).</li><li>Avila, M., Gonzalez-Espinosa, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Signaling+through+Toll-like+receptor+4+and+mast+cell-dependent+innate+immunity+responses.">Signaling through Toll-like receptor 4 and mast cell-dependent innate immunity responses.</a> IUBMB Life. 63 (10), 873-880 (2011).</li><li>Novak, N., Bieber, T., Peng, W. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+immunoglobulin+E-Toll-like+receptor+network.">The immunoglobulin E-Toll-like receptor network.</a> Int Arch Allergy Immunol. 151 (1), 1-7 (2010).</li><li>Rudich, N., Ravid, K., Sagi-Eisenberg, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mast+cell+adenosine+receptors+function:+a+focus+on+the+a3+adenosine+receptor+and+inflammation.">Mast cell adenosine receptors function: a focus on the a3 adenosine receptor and inflammation.</a> Front Immunol. 3, 134 (2012).</li><li>Theoharides, T. C., Kempuraj, D., Tagen, M., Conti, P., Kalogeromitros, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Differential+release+of+mast+cell+mediators+and+the+pathogenesis+of+inflammation.">Differential release of mast cell mediators and the pathogenesis of inflammation.</a> Immunol Rev. 217, 65-78 (2007).</li><li>Caughey, G. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mast+cell+proteases+as+protective+and+inflammatory+mediators.">Mast cell proteases as protective and inflammatory mediators.</a> Adv Exp Med Biol. 716, 212-234 (2011).</li><li>Lundequist, A., Pejler, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Biological+implications+of+preformed+mast+cell+mediators.">Biological implications of preformed mast cell mediators.</a> Cell Mol Life Sci. 68 (6), 965-975 (2011).</li><li>Metz, M., Maurer, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mast+cells--key+effector+cells+in+immune+responses.">Mast cells--key effector cells in immune responses.</a> Trends Immunol. 28 (5), 234-241 (2007).</li><li>Gordon, J. R., Burd, P. R., Galli, S. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mast+cells+as+a+source+of+multifunctional+cytokines.">Mast cells as a source of multifunctional cytokines.</a> Immunol Today. 11 (12), 458-464 (1990).</li><li>Azouz, N. P., Matsui, T., Fukuda, M., Sagi-Eisenberg, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Decoding+the+regulation+of+mast+cell+exocytosis+by+networks+of+Rab+GTPases.">Decoding the regulation of mast cell exocytosis by networks of Rab GTPases.</a> J Immunol. 189 (5), 2169-2180 (2012).</li><li>Stenmark, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Inhibition+of+rab5+GTPase+activity+stimulates+membrane+fusion+in+endocytosis.">Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis.</a> EMBO J. 13 (6), 1287-1296 (1994).</li><li>Azouz, N. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Rab5+is+a+novel+regulator+of+mast+cell+secretory+granules:+impact+on+size,+cargo,+and+exocytosis.">Rab5 is a novel regulator of mast cell secretory granules: impact on size, cargo, and exocytosis.</a> J Immunol. 192 (9), 4043-4053 (2014).</li></ol>

The authors have no financial conflicts of interest.

We describe an innovative strategy that combines quantification of MCs exocytosis and four (x, y, z, t) dimension quantifications by time-lapsed three-dimensional imaging of the SGs in living cells using a reporter gene for exocytosis. This technique enables screening of families of proteins for their impact on MC function such as monitoring SGs starting as early as their exit from the Golgi through their maturation, acquisition of exocytosis competence and degranulation. The combination of&#160;measurements of exocytosi...

Mast Cells (MC) are immune cells that are best known for their involvement in allergic and inflammatory reactions such as arthritis, asthma, eosinophilic esophagitis, chronic dermatitis and anaphylactic shock 1,2 as well as other pathologies including coronary artery disease 3,5 and cancer 3,4. In addition, MCs play important roles in innate and adaptive immunity, both in host defense against bacteria and parasites and by suppression of immune responses, for example inducing allograft tolerance 5,6 .
MCs originate from the bone marrow, developing from CD34+/CD117+ pluripotent progenitor cells 7. Committed bone marrow MC&#160;progenitors are released into the bloodstream and migrate into the peripheral tissues localizing predominantly within connective tissues and epithelial surfaces 8. Maturation and terminal differentiation are eventually achieved under the influence of cytokines within the surrounding milieu 8,9 .
MCs can be activated by an allergen (antigen, Ag), whose encounter resulted in the generation of immunoglobulin E (IgE) type antibodies. Binding of such IgE to the MC&#8217;s Fc&#949;RI receptors, followed by cross-linking of cell bound IgE upon re-exposure to the same Ag, results in Fc&#949;RI aggregation and initiation of a signaling cascade that culminates in cell degranulation [reviewed in 10,11]. MCs are also activated, independently of IgE, by neuropeptides 5,12, toxins 13 , bacterial and viral antigens 14,15, a number of positively charged peptides collectively referred to as basic secretagogues, immune cells and cytokines 5,13,12,16,17. MCs are also activated by many of their own released mediators, which further amplify the inflammatory response.
MCs are packed with secretory granules (SGs) that contain immunoregulatory mediators, including vasoactive amines, such as histamine and serotonin (in rodents), proteoglycans, proteases, such as chymase and tryptase, vascular endothelial growth factor and several cytokines and chemokines 8,9. These mediators are &#8220;ready to go&#8221; and once MCs are activated by an appropriate stimulus, these mediators are released from the cells by regulated exocytosis (degranulation) in a matter of seconds to minutes 18,19. This initial event is followed by the de novo synthesis and release of a large array of biologically potent substances, including arachidonic acid metabolites, multiple cytokines and chemokines 20,21,22. Release of newly synthesized products occurs independently of SG release. Collectively, these mediators initiate early and late phase inflammatory and allergic responses. Therefore, understanding the mechanisms accounting for MC activation and degranulation are both of theoretical and clinical importance.
The difficulty to genetically manipulate primary and cultured MCs has hampered the attempts to elucidate the mechanisms underlying MC degranulation, which remained poorly resolved. To overcome this problem we developed a reporter based assay by co-transfecting the mucosal mast cell line, rat basophilic leukemia (RBL)-2H3 (herein referred to as RBL) or bone marrow derived MCs&#160;(BMMCs) 30 with a gene of interest and Neuropeptide Y (NPY) fused to monomeric RFP (mRFP), as a SG reporter.
NPY was previously shown to recapitulate the behavior of endogenous SG markers in other systems. Moreover, because mRFP fluorescence is pH insensitive, expression of NPY-mRFP allows visualization of the acidic SGs as well as quantitative assessment of exocytosis by using 96-well plates and a fluorescence plate reader. We have shown that NPY-mRFP is delivered to the acidic SGs of RBL cells and BMMCs and is released from the cells in a regulated fashion alongside the endogenous SG&#160;cargo (i.e., &#946;-hexosaminidase and serotonin) 30,32 . This protocol provides a high-resolution imaging-based methodology that allows screening genes of interest for their phenotypic and functional impact on SG characteristics and degranulation in RBL cells 32. Specifically, this protocol allows real time tracking of MC SGs and quantification of their area or volume size, their number, kinetics of assembly, their movement along the cell cytoskeleton and their ultimate fusion with the plasma membrane under different conditions. For example, sensitizing the cells with DNP-specific IgE and triggering the cells with a multivalent Ag (DNP conjugated serum albumin) under different perturbations (i.e., knockdown of genes of interest, over expression of wt or mutant genes, or pharmacological manipulations) and comparing to control cells.

<table><tbody><tr><td>DMEM</td><td>Sigma-Aldrich</td><td>D6046-500ML</td><td>Warm in 37 &amp;deg;C water bath before use</td></tr><tr><td>Fetal Bovine Serum</td><td>GE health care Life sciences</td><td>SH30071.01</td><td></td></tr><tr><td>Penicillin-Streptomycin</td><td>Life technologies</td><td></td><td></td></tr><tr><td>Cellulose acetate membrane, pore size 0.22&amp;nbsp;&amp;mu;m</td><td>Sigma-Aldrich</td><td>CLS430769-1EA</td><td></td></tr><tr><td>Corning tissue-culture treated culture dishes</td><td>Sigma-Aldrich</td><td>CLS430167</td><td></td></tr><tr><td>Trypsin/EDTA Solution (TE)</td><td>Life technologies</td><td>R001100</td><td>Warm in 37 &amp;deg;C water bath before use</td></tr><tr><td>PIPES dipotassium salt</td><td>Sigma-Aldrich</td><td>108321-27-3&amp;nbsp;</td><td></td></tr><tr><td>Calcium acetate hydrate</td><td>Sigma-Aldrich</td><td>114460-21-8</td><td></td></tr><tr><td>Magnesium acetate tetrahydrate</td><td>Sigma-Aldrich</td><td>M5661&amp;nbsp;</td><td></td></tr><tr><td>L-Glutamic acid potassium salt monohydrate (Potassium glutamate)</td><td>Sigma-Aldrich</td><td>G1501</td><td></td></tr><tr><td>4 mm electroporation cuvettes</td><td>cell projects</td><td>EP-104</td><td></td></tr><tr><td>GENE PULSER WITH PULSE CONTROLLER &amp;amp; CAPACITANCE</td><td>Bio rad</td><td></td><td></td></tr><tr><td>Chambered coverglass</td><td>Thermo scientific</td><td>155411</td><td></td></tr><tr><td>24 well, flat bottom</td><td>Sigma-Aldrich</td><td>CLS3524</td><td></td></tr><tr><td>Corning 96 well plates</td><td>Sigma-Aldrich</td><td>CLS3367 or CLS390</td><td></td></tr><tr><td>96 well plate fluorescence reader- Infinite 200</td><td>Tecan</td><td></td><td></td></tr><tr><td>Calcium ionophore A23187</td><td>Sigma-Aldrich</td><td>C7522</td><td>Avoid from direct light exposure</td></tr><tr><td>12-O-tetradecanoyl-13-acetate (TPA)</td><td>Calbiochem</td><td>P3766</td><td></td></tr><tr><td>anti-DNP monoclonal IgE</td><td>Sigma-Aldrich</td><td>D8406&amp;nbsp;</td><td></td></tr><tr><td>DNP-BSA/ DNP-HAS</td><td>Sigma-Aldrich</td><td>A6661</td><td>Avoid from direct light exposure</td></tr><tr><td>Triton-x-100</td><td>Sigma-Aldrich</td><td>T8787</td><td></td></tr><tr><td>Confocal fluorescent microscope:</td><td></td><td></td><td></td></tr><tr><td>Zeiss LSM 510</td><td></td><td></td><td></td></tr><tr><td>Leica</td><td>SP5</td><td></td><td></td></tr><tr><td>Nikon A1 inverted</td><td></td><td></td><td></td></tr><tr><td>Imaris software</td><td>BITLANE</td><td></td><td></td></tr><tr><td>Microsoft exel or Prism or other analyses software</td><td></td><td></td><td></td></tr><tr><td>Other reagent:</td><td></td><td></td><td></td></tr><tr><td>Magnesium Chloride</td><td>MERK</td><td>5833</td><td></td></tr><tr><td>Sodium chloride</td><td>MERK</td><td>6404</td><td></td></tr><tr><td>Calcium chloride&amp;nbsp;</td><td>MERK</td><td>2382</td><td></td></tr><tr><td>Bovine serum albumin&amp;nbsp;</td><td>Sigma-Aldrich</td><td>A4503</td><td></td></tr><tr><td>Glucose</td><td>BDH Laboratories</td><td>284515V</td><td></td></tr><tr><td>Monosodium phosphate&amp;nbsp;</td><td>MERK</td><td>5345</td><td></td></tr><tr><td>Sterile water</td><td></td><td></td><td></td></tr></tbody></table>

investigating mast cell secretory granules; from biosynthesis to exocytosis

Mast Cells (MC) are secretory cells of the immune system that accomplish their physiological and pathological functions by releasing pre-formed and newly synthesized allergic, inflammatory and immunoregulatory mediators. MCs&#8217; mediators affect multiple tissues and organs culminating in allergic and immune responses. The synthesis, storage and release of the MC mediators are highly regulated. The pre-formed mediators are packed in cytoplasmic secretory granules&#160;(SG) that fuse with the plasma membrane and release their content by regulated exocytosis. We present a protocol, based on the co-expression of a gene of interest with a reporter gene that is targeted to the SGs and is released in a regulated fashion alongside the endogenous SG mediators. The protocol enables high resolution four dimensional confocal analyses of the MC SGs and monitoring their timeline from biogenesis to triggered exocytosis. Thus, using this protocol for screening genes of interest for their phenotypic and functional impact allows deciphering the molecular mechanisms that govern the biogenesis and exocytosis of the MC SGs and identifying the regulators involved. Thereby, further insights into the cellular mechanisms that account for MCs function in health and disease should be provided.

Because of the low transfection efficiency of MCs, genetic manipulations are unlikely to leave an impact on readouts of average secretion measured by endogenous SGs mediators. Nevertheless, by establishing complete co-expression of the reporter gene NPY-mRFP and the co-transfected plasmid at the same cells, monitoring of NPY-mRFP results in monitoring exclusively the cell population that expresses the gene of interest. Therefore, the advantage of this assay compared to conventional methods is the ability to selectively m...

Watch this Scientific Journal Video about Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis at JoVE.com

Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis

The goal of the present&#160;protocol was to develop a method that will allow functional genomic analyses of mast cell secretion. The protocol is based on quantitative assessment of the release of a fluorescent reporter gene cotrasfected with the gene of interest and real time&#160;analyses of the secretory granule&#39;s morphology.

Mast Cells (MC) are secretory cells of the immune system that accomplish their physiological and pathological functions by releasing pre-formed and newly ...

investigating-mast-cell-secretory-granules-from-biosynthesis-to

Research

JoVE Journal

Immunology and Infection

13.1K Views.  Sackler Faculty of Medicine, Tel Aviv University.  Het doel van het huidige protocol was om een ​​methode die functioneel genomische analyses van mestcel secretie zal ontwikkelen. Het protocol is gebaseerd op kwantitatieve beoordeling van de release van een tl-reporter-gen cotrasfected met het gen van interesse en real-time analyses van de morfologie van de secretoire korrel's. 

Video: Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis

A Microplate Assay to Assess Chemical Effects on RBL-2H3 Mast Cell Degranulation: Effects of Triclosan without Use of an Organic Solvent

Mast cells play important roles in allergic disease and immune defense against parasites. Once activated (e.g. by an allergen), they degranulate, a process that results in the exocytosis of allergic mediators. Modulation of mast cell degranulation by drugs and toxicants may have positive or adverse effects on human health. Mast cell function has been dissected in detail with the use of rat basophilic leukemia mast cells (RBL-2H3), a widely accepted model of human mucosal mast cells3-5. Mast cell granule component and the allergic mediator &#946;-hexosaminidase, which is released linearly in tandem with histamine from mast cells6, can easily and reliably be measured through reaction with a fluorogenic substrate, yielding measurable fluorescence intensity in a microplate assay that is amenable to high-throughput studies1. Originally published by Naal et al.1, we have adapted this degranulation assay for the screening of drugs and toxicants and demonstrate its use here.
Triclosan is a broad-spectrum antibacterial agent that is present in many consumer products and has been found to be a therapeutic aid in human allergic skin disease7-11, although the mechanism for this effect is unknown. Here we demonstrate an assay for the effect of triclosan on mast cell degranulation. We recently showed that triclosan strongly affects mast cell function2. In an effort to avoid use of an organic solvent, triclosan is dissolved directly into aqueous buffer with heat and stirring, and resultant concentration is confirmed using UV-Vis spectrophotometry (using &#949;280 = 4,200 L/M/cm)12. This protocol has the potential to be used with a variety of chemicals to determine their effects on mast cell degranulation, and more broadly, their allergic potential.

Mast cell degranulation, the release of allergic mediators, is important in allergy, asthma, and parasite defense. Here we demonstrate techniques1 for assessing effects of drugs and toxicants on degranulation, methodology recently utilized to exhibit the powerful inhibitory effect of antibacterial agent triclosan2.

Mast cells play important roles in allergic disease and immune defense against parasites. Once activated (e.g. by an allergen), they degranulate, a ...

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays

Mast cells (MCs), as a part of the immune system, play a key role in defending the host against several pathogens and in the initiation of the allergic immune response. The activation of MCs via the cross-linking of surface IgE bound to high affinity IgE receptor (Fc&#949;RI), as well as through the stimulation of several other receptors, initiates the rise of the free intracellular Ca2+ level ([Ca2+]i) that promotes the release of inflammatory and allergic mediators. The identification of molecular constituents involved in these signaling pathways is crucial for understanding the regulation of MC function. In this article, we describe a protocol for the isolation of murine connective tissue type MCs by peritoneal lavage and cultivation of peritoneal MCs (PMCs). Cultures of MCs from various knockout mouse models by this methodology represent a useful approach to the identification of proteins involved in MC signaling pathways. In addition, we also describe a protocol for single cell Fura-2 imaging as an important technique for the quantification of Ca2+ signaling in MCs. Fluorescence-based monitoring of [Ca2+]i is a reliable and commonly used approach to study Ca2+ signaling events, including store-operated calcium entry, which is of utmost importance for MC activation. For the analysis of MC degranulation, we describe a &#946;-hexosaminidase release assay. The amount of &#946;-hexosaminidase released into the culture medium is considered as a degranulation marker for all three different secretory subsets described in MCs. &#946;-hexosaminidase can easily be quantified by its reaction with a colorigenic substrate in a microtiter plate colorimetric assay. This highly reproducible technique is cost-effective and requires no specialized equipment. Overall, the provided protocol demonstrates a high yield of MCs expressing typical MC surface markers, displaying typical morphological and phenotypic features of MCs, and demonstrating highly reproducible responses to secretagogues in Ca2+-imaging and degranulation assays.

Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays

Here, we present a protocol to isolate and cultivate murine peritoneal mast cells. We also describe two protocols for their functional characterization: a fluorescent imaging of intracellular free Ca2+ concentration and a degranulation assay based on colorimetric quantification of the released &#946;-hexosaminidase.

Mast cells (MCs), as a part of the immune system, play a key role in defending the host against several pathogens and in the initiation of the allergic ...

Monitoring the Effect of Osmotic Stress on Secretory Vesicles and Exocytosis

Amperometry recording of cells subjected to osmotic shock show that secretory cells respond to this physical stress by reducing the exocytosis activity and the amount of neurotransmitter released from vesicles in single exocytosis events. It has been suggested that the reduction in neurotransmitters expelled is due to alterations in membrane biophysical properties when cells shrink in response to osmotic stress and with assumptions made that secretory vesicles in the cell cytoplasm are not affected by extracellular osmotic stress. Amperometry recording of exocytosis monitors what is released from cells the moment a vesicle fuses with the plasma membrane, but does not provide information on the vesicle content before the vesicle fusion is triggered. Therefore, by combining amperometry recording with other complementary analytical methods that are capable of characterizing the secretory vesicles before exocytosis at cells is triggered offers a broader overview for examining how secretory vesicles and the exocytosis process are affected by osmotic shock. We here describe how complementing amperometry recording with intracellular electrochemical cytometry and transmission electron microscopy (TEM) imaging can be used to characterize alterations in secretory vesicles size and neurotransmitter content at chromaffin cells in relation to exocytosis activity before and after exposure to osmotic stress. By linking the quantitative information gained from experiments using all three analytical methods, conclusions were previously made that secretory vesicles respond to extracellular osmotic stress by shrinking in size and reducing the vesicle quantal size to maintain a constant vesicle neurotransmitter concentration. Hence, this gives some clarification regarding why vesicles, in response to osmotic stress, reduce the amount neurotransmitters released during exocytosis release. The amperometric recordings here indicate this is a reversible process and that vesicle after osmotic shock are refilled with neurotransmitters when placed cells are reverted into an isotonic environment.

Osmotic stress affects exocytosis and the amount of neurotransmitter released during this process. We demonstrate how combining electrochemical methods together with transmission electron microscopy can be used to study the effect of extracellular osmotic pressure on exocytosis activity, vesicle quantal size, and the amount of neurotransmitter released during exocytosis.

Amperometry recording of cells subjected to osmotic shock show that secretory cells respond to this physical stress by reducing the exocytosis activity ...

Neuroscience

An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation

Mast cell stabilizers are an essential part of allergy medication. Passive systemic anaphylaxis (PSA) is an animal assay widely used for investigating the effect of a pharmacological agent of interest on mast cells in vivo. As the anaphylactic symptoms are primarily attributed to exocytosis of the granules from mast cells, it is conceived that the agent to cause amelioration of the symptoms has a mast cell stabilizing activity. Despite the fact, it is prudent to confirm the activity by directly demonstrating the decline in the functional activity of mast cells following its treatment. In vitro degranulation assays using an immortalized mast cell line or cultured primary mast cells are routinely employed to that end. The results from the in vitro and in vivo assays may not always be akin to each other; however, as treatment conditions (e.g., treatment dose, time, surrounding environments) for the in vitro assays are often distinct from those for the in vivo assay such as PSA. In pursuit of an in vitro (or ex vivo) assay to reflect more closely the effect of a pharmacological agent on mast cells in vivo, we devised the ex vivo mast cell degranulation assay in which crude peritoneal exudate cells (PECs) isolated from the mice, treated with the agent and administered anti-dinitrophenol (DNP) IgE, were incubated directly with DNP on a carrier protein. It turned out that the assay was not only useful in validating the mast cell stabilizing activity of a pharmacological agent indicated by the in vivo assay but also practical and highly reproducible.

We have established an ex vivo mast cell degranulation assay carried out by incubating crude peritoneal exudate cells isolated from the mice, treated with a pharmacological agent of interest and administered anti-dinitrophenol (DNP) IgE beforehand, with DNP on a carrier protein.

Mast cell stabilizers are an essential part of allergy medication. Passive systemic anaphylaxis (PSA) is an animal assay widely used for investigating the ...

Confocal Imaging of Neuropeptide Y-pHluorin: A Technique to Visualize Insulin Granule Exocytosis in Intact Murine and Human Islets

Insulin secretion plays a central role in glucose homeostasis under normal physiological conditions as well as in disease. Current approaches to study insulin granule exocytosis either use electrophysiology or microscopy coupled to the expression of fluorescent reporters. However most of these techniques have been optimized for clonal cell lines or require dissociating pancreatic islets. In contrast, the method presented here allows for real time visualization of insulin granule exocytosis in intact pancreatic islets. In this protocol, we first describe the viral infection of isolated pancreatic islets with adenovirus that encodes a pH-sensitive green fluorescent protein (GFP), pHluorin, coupled to neuropeptide Y (NPY). Second, we describe the confocal imaging of islets five days after viral infection and how to monitor the insulin granule secretion. Briefly, the infected islets are placed on a coverslip on an imaging chamber and imaged under an upright laser-scanning confocal microscope while being continuously perfused with extracellular solution containing various stimuli. Confocal images spanning 50 &#181;m of the islet are acquired as time-lapse recordings using a fast-resonant scanner. The fusion of insulin granules with the plasma membrane can be followed over time. This procedure also allows for testing a battery of stimuli in a single experiment, is compatible with both mouse and human islets, and can be combined with various dyes for functional imaging (e.g., membrane potential or cytosolic calcium dyes).

We describe a protocol for visualization of insulin exocytosis in intact islets using pHluorin, a pH-sensitive green fluorescent protein. Isolated islets are infected with adenovirus encoding pHluorin coupled to the vesicle cargo neuropeptide Y. This allows for the detection of insulin granule fusion events by confocal microscopy.

Insulin secretion plays a central role in glucose homeostasis under normal physiological conditions as well as in disease. Current approaches to study ...

Biology

Imaging FITC-dextran as a Reporter for Regulated Exocytosis

Regulated exocytosis is a process by which cargo, which is stored in secretory granules (SGs), is released in response to a secretory trigger. Regulated exocytosis is fundamental for intercellular communication and is a key mechanism for the secretion of neurotransmitters, hormones, inflammatory mediators, and other compounds, by a variety of cells. At least three distinct mechanisms are known for regulated exocytosis: full exocytosis, where a single SG fully fuses with the plasma membrane, kiss-and-run exocytosis, where a single SG transiently fuses with the plasma membrane, and compound exocytosis, where several SGs fuse with each other, prior to or after SG fusion with the plasma membrane. The type of regulated exocytosis undertaken by a cell is often dictated by the type of secretory trigger. However, in many cells, a single secretory trigger can activate multiple modes of regulated exocytosis simultaneously. Despite their abundance and importance across cell types and species, the mechanisms that determine the different modes of secretion are largely unresolved. One of the main challenges in investigating the different modes of regulated exocytosis, is the difficulty in distinguishing between them as well as exploring them separately. Here we describe the use of fluorescein isothiocyanate (FITC)-dextran as an exocytosis reporter, and live cell imaging, to differentiate between the different pathways of regulated exocytosis, focusing on compound exocytosis, based on the robustness and duration of the exocytic events.

Here we detail a method for live cell imaging of regulated exocytosis. This method utilizes FITC-dextran, which accumulates in lysosome-related organelles, as a reporter. This simple method also allows distinguishing between different modes of regulated exocytosis in cells that are difficult to manipulate genetically.

Regulated exocytosis is a process by which cargo, which is stored in secretory granules (SGs), is released in response to a secretory trigger. Regulated ...

Quantifying Spatiotemporal Parameters of Cellular Exocytosis in Micropatterned Cells

Live imaging of the pHluorin tagged Soluble N-ethylmaleimide-sensitive-factor Attachment protein REceptor (v-SNARE) Vesicle-associated membrane protein 7 (VAMP7) by total internal reflection fluorescence microscopy (TIRFM) is a straightforward way to explore secretion from the lysosomal compartment. Taking advantage of cell culture on micropatterned surfaces to normalize cell shape, a variety of statistical tools were employed to perform a spatial analysis of secretory patterns. Using Ripley&#8217;s K function and a statistical test based on the nearest neighbor distance (NND), we confirmed that secretion from lysosomes is not a random process but shows significant clustering. Of note, our analysis revealed that exocytosis events are also clustered in nonadhesion areas, indicating that adhesion molecules are not the only structures that can induce secretory hot spots at the plasma membrane. Still, we found that cell adhesion enhances clustering. In addition to precisely defined adhesive and nonadhesive areas, the circular geometry of these micropatterns allows the use of polar coordinates, simplifying analyses. We used Kernel Density Estimation (KDE) and the cumulative distribution function on polar coordinates of exocytosis events to identify enriched areas of exocytosis. In ring-shaped micropattern cells, clustering occurred at the border between the adhesive and nonadhesive areas. Our analysis illustrates how statistical tools can be employed to investigate spatial distributions of diverse biological processes.

Live imaging of lysosomal exocytosis on micropatterned cells allows a spatial quantification of this process. Morphology normalization using micropatterns is an outstanding tool to uncover general rules about the spatial distribution of cellular processes.

Live imaging of the pHluorin tagged Soluble N-ethylmaleimide-sensitive-factor Attachment protein REceptor (v-SNARE) Vesicle-associated membrane protein 7 ...

Mast Cell Degranulation Assay to Study the Effect of a Target Chemical

Source: Tsvilovskyy, V., et al. <a href="https://app.jove.com/v/57222">Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation Assays.</a>&#160;J. Vis. Exp. (2018).
This video demonstrates a colorimetric assay to determine the degranulation activity of mast cells. The enzyme released by the mast cells hydrolyzes the substrate and produces a colored product. The degranulation activity of the mast cells was measured as the percentage release of enzymes outside the cell normalized with the total enzyme content in the cell.

Source: Tsvilovskyy, V., et al. Isolation of Peritoneum-derived Mast Cells and Their Functional Characterization with Ca2+-imaging and Degranulation ...

JoVE Encyclopedia of Experiments

Immunology

Immune Systems and Components

Assays and Functional Profiling

Measuring Mast Cell Exocytosis via Neuropeptide Y Monomeric Red Fluorescent Protein Release

Source: Azouz, N. P., et al., <a href="https://app.jove.com/v/52505">Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis.</a> J. Vis. Exp. (2015)
This video demonstrates mast cell exocytosis induced by an activating reagent that includes a calcium ionophore, initiating the release of secretory granules containing the fluorescent reporter protein NPY-mRFP. Subsequently, we quantitatively assess the exocytosis by measuring the released NPY-mRFP using a fluorescence plate reader.

1. Measuring NPY-mRFP Exocytosis

	Preparation of Tyrode buffer:
	
		Prepare a solution of 54 mM KCl, 20 mM MgCl2, 2.74 M NaCl, and 8 mM NaH2PO4 in DDW. ...

Immunodiagnostics

Cellular Immunodiagnostics

Overview of Secretory Vesicles

Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins (Cgs) A and B are proteins that bind to soluble molecules present in secretory vesicles. This binding aggregates the soluble molecules, forming DCVs. Cgs function optimally at low pH and high intracellular calcium concentration. The low pH is maintained by the continuous pumping of protons by the V-type ATPases. A high concentration of calcium is present in the endoplasmic reticulum and Golgi complex of most mammalian cells. Hence, the secretory vesicles that bud off from the trans-Golgi network are rich in calcium. Calcium induces pH-dependent conformational changes in Cgs A and B. These conformational changes lead to the binding and aggregation of CgsA and B among other vesicular matrix proteins with the vesicular membrane. Aggregation is important for specific proteins to be sorted into regulated secretory vesicles.
The yeast Saccharomyces cerevisiae is a model system for studying the regulation of secretory vesicle-mediated transport. In 1979, Randy Schekman and Peter Novik generated temperature-sensitive mutants of S. cerevisiae. These mutants expressed proteins that were functional only at low temperatures but not at 37&#176;C. Schekman and Novik observed that these mutants accumulated vesicles and internal membranes. These mutants were also defective in different stages of protein secretion and therefore called them sec mutants. Some sec mutants contained vesicles that were unable to fuse with the plasma membrane, while other mutants could not transport proteins to other organelles. Further, molecular analysis of these mutants revealed 23 sec genes that produced proteins with regulatory roles in different transport stages of secretory vesicles.

Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis

Samenvatting

Meer video's verkennen